Navigation Links
CCNY professor gets grant to develop 'artificial blood'
Date:12/7/2010

As a post-doc at The University of Pennsylvania, Dr. Ron Koder, assistant professor of physics at The City College of New York, was part of a team that devised a novel method for producing an artificial protein capable of transporting oxygen, similar to human neuroglobin. He was recently awarded a three-year $1.3 million grant from the U.S. Department of Defense to develop an artificial blood that can be administered to injured troops on the battlefield.

"Engineered blood substitutes have a lot of attractive properties compared to blood drawn from people," he said. "No typing is required, you don't have to worry about refrigeration or freshness and there is no risk of infection." They can save lives, as well, since severely wounded servicemen and women sometimes die before they can be transported to a hospital and given a transfusion.

Professor Koder will use the grant to conduct laboratory studies to improve the stability and other properties of the protein. Then, he plans to cross-link the protein into large aggregates to create particles the same size as red blood cells.

Because the artificial hemoglobin binds oxygen in the presences of carbon monoxide, the substance also has the potential to prevent or treat carbon monoxide poisoning, he noted. However, this will not be part of the investigation.

Research like Professor Koder's investigation is part of the emerging field of biological design, a system for producing biological materials from scratch. Other potential applications include fighting AIDS and alternative energy. Biological design was the topic of a daylong symposium Friday, December 3, at the New York Academy of Sciences that Professor Koder helped organize.

"Natural materials are fussy. It's hard to get them to interact," he explained. "The (manmade) stuff is better for engineering more complex systems." Some of the biological design projects underway include developing metabolic pathways that could produce low-cost AIDS drugs, using solar energy to produce bio-fuels through artificial photosynthesis and making methanol from carbon dioxide.


'/>"/>

Contact: Ellis Simon
esimon@ccny.cuny.edu
212-650-6460
City College of New York
Source:Eurekalert

Related biology news :

1. Rensselaer Polytechnic Institute professor Georges Belfort wins biochemical engineering award
2. UTHealth School of Biomedical Informatics professor to be inducted to AIMBE College of Fellows
3. ASU professor named top in state of Arizona
4. UH engineering professors featured in consecutive issues of Science
5. Falling in love more scientific than you think, according to Syracuse University professor
6. NJIT professor helps make case in Science for better biodiversity
7. 1 step closer to a drug treatment for cystic fibrosis, MU professor says
8. USDA awards grant to GSU professor to study childhood obesity dynamics
9. UD Professor Emeritus wins Nobel Prize in Chemistry
10. Louisiana Tech professor partners with local schools to study menu nutrition
11. Nobel Prize for Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology: